Impact of Fascia Iliaca Block in Hip Fracture Patients

May 23, 2019 updated by: Mai P. Nguyen, Texas Tech University Health Sciences Center, El Paso

Impact of Fascia Iliaca Block on Pain Outcomes and Opioid Consumption for Hip Fracture Patients-A Prospective, Randomized Study

The study is a prospective randomized examining the impact of fascia iliaca block on perioperative pain control and post operative ambulation in patients with hip fractures.

Study Overview

Detailed Description

Regional anesthesia is an important element of multimodal pain control regimen for surgical patients. Recently, regional anesthesia using a fascia iliaca block (FIB) to help treat pain in patients who present with hip fractures has been gaining popularity and has been incorporated as part of a multi-modal pain control protocol in many centers. It is commonly offered in addition to oral and intravenous medications to help patients deal with pain in the perioperative period. The block is done by an anesthesiologist under anesthesia using ultrasound guidance. We propose a prospective, randomized study evaluating the efficacy of the FIB as an adjunct in the pre-operative or postoperative period for pain control as measured by visual analog scale (VAS) scores and morphine equivalent dosing (MED), as well as its efficacy in promoting patient participation in physical therapy postoperatively in patients who present with hip fractures. We hypothesize that those patients who receive FIBs will report lower VAS scores as well as decreased narcotic requirement at all time points; and have improved participation in therapy when measured by ambulation distance.

Study Type

Interventional

Enrollment (Actual)

97

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • El Paso, Texas, United States, 79905
        • University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with femoral neck and intertrochanteric hip fractures
  • At least 18 years of age
  • Require operative management

Exclusion Criteria:

  • Poly-trauma patients
  • Pathologic fractures
  • Patient who required revision procedures
  • Patients with chronic opioid use
  • Patients with a clinical status that precludes verbal pain assessment such as dementia, head injuries, and unwillingness to participate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Control
Patients in the control arm will receive pain control via traditional oral and intravenous pain medications such as opioids and non-steroidal anti-inflammatory medication as needed.
EXPERIMENTAL: Fascia iliaca block
Patients in the intervention arm will receive the regional fascia iliaca block performed by the anesthesiologists on call.
The fascia iliaca block will be performed by the anesthesiologist on call
Other Names:
  • FIB

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain level
Time Frame: Pre operatively
Visual analog scale scores (from 0-10 with 0 being no pain and 10 being the worst pain)
Pre operatively
Pain medication requirement
Time Frame: Pre operatively
Morphine equivalent dosing
Pre operatively
Pain level
Time Frame: Four hours after surgery
Visual analog scale scores (from 0-10 with 0 being no pain and 10 being the worst pain)
Four hours after surgery
Pain medication requirement
Time Frame: Four hours after surgery
Morphine equivalent dosing
Four hours after surgery
Pain level
Time Frame: One day after surgery
Visual analog scale scores (from 0-10 with 0 being no pain and 10 being the worst pain)
One day after surgery
Pain medication requirement
Time Frame: One day after surgery
Morphine equivalent dosing
One day after surgery
Pain level
Time Frame: Two days after surgery
Visual analog scale scores (from 0-10 with 0 being no pain and 10 being the worst pain)
Two days after surgery
Pain medication requirement
Time Frame: Two days after surgery
Morphine equivalent dosing
Two days after surgery
Pain level
Time Frame: Three days after surgery
Visual analog scale scores and morphine equivalent dosing
Three days after surgery
Pain medication requirement
Time Frame: Three days after surgery
Morphine equivalent dosing
Three days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ambulation distance
Time Frame: Two days after surgery
Ambulation distance with physical therapy post op
Two days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mai Nguyen, MD, Texas Tech University Health Sciences Center, El Paso

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 20, 2018

Primary Completion (ACTUAL)

May 1, 2019

Study Completion (ACTUAL)

May 1, 2019

Study Registration Dates

First Submitted

May 3, 2018

First Submitted That Met QC Criteria

May 3, 2018

First Posted (ACTUAL)

May 16, 2018

Study Record Updates

Last Update Posted (ACTUAL)

May 28, 2019

Last Update Submitted That Met QC Criteria

May 23, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • E18046

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)

Clinical Trials on Fascia iliaca block arm

Subscribe